These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of oral antifungals and their clinical implications. Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419 [TBL] [Abstract][Full Text] [Related]
3. The triazole antifungal agents: a review of itraconazole and fluconazole. Bailey EM; Krakovsky DJ; Rybak MJ Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523 [TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacokinetics of itraconazole: an overview. Heykants J; Van Peer A; Van de Velde V; Van Rooy P; Meuldermans W; Lavrijsen K; Woestenborghs R; Van Cutsem J; Cauwenbergh G Mycoses; 1989; 32 Suppl 1():67-87. PubMed ID: 2561187 [TBL] [Abstract][Full Text] [Related]
6. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479 [TBL] [Abstract][Full Text] [Related]
7. Itraconazole. Med Lett Drugs Ther; 1993 Jan; 35(888):7-9. PubMed ID: 8380485 [No Abstract] [Full Text] [Related]
8. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages. Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051 [TBL] [Abstract][Full Text] [Related]
9. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Grant SM; Clissold SP Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949 [TBL] [Abstract][Full Text] [Related]
10. Role of animal and human pharmacology in antifungal drug design. Cauwenbergh G; Van Cutsem J Ann N Y Acad Sci; 1988; 544():264-9. PubMed ID: 2850750 [TBL] [Abstract][Full Text] [Related]
11. Skin kinetics of azole antifungal drugs. Cauwenbergh G Curr Top Med Mycol; 1992; 4():88-136. PubMed ID: 1310076 [No Abstract] [Full Text] [Related]
12. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis. Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole released for blastomycosis and histoplasmosis therapy. Clin Pharm; 1993 Jan; 12(1):6-7. PubMed ID: 8381341 [No Abstract] [Full Text] [Related]
14. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. Van Peer A; Woestenborghs R; Heykants J; Gasparini R; Gauwenbergh G Eur J Clin Pharmacol; 1989; 36(4):423-6. PubMed ID: 2544431 [TBL] [Abstract][Full Text] [Related]
15. Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses. Odds FC J Dermatol Sci; 1993 Apr; 5(2):65-72. PubMed ID: 8395201 [TBL] [Abstract][Full Text] [Related]
17. Itraconazole: pharmacologic studies in animals and humans. Van Cauteren H; Heykants J; De Coster R; Cauwenbergh G Rev Infect Dis; 1987; 9 Suppl 1():S43-6. PubMed ID: 3027845 [TBL] [Abstract][Full Text] [Related]
18. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Lim SG; Sawyerr AM; Hudson M; Sercombe J; Pounder RE Aliment Pharmacol Ther; 1993 Jun; 7(3):317-21. PubMed ID: 8117350 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare. Faergemann J Antimicrob Agents Chemother; 1984 Nov; 26(5):773-4. PubMed ID: 6097177 [TBL] [Abstract][Full Text] [Related]
20. Azole antifungal drugs: old and new. Dismukes WE Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058 [No Abstract] [Full Text] [Related] [Next] [New Search]